Article Information
History
- October 6, 2021.
Article Versions
- Version 1 (June 22, 2021 - 13:58).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Beatrice Casati1,2,
- Joseph Peter Verdi1,3,
- Alexander Hempelmann3,
- Maximilian Kittel4,6,
- Andrea Gutierrez Klaebisch5,6,
- Bianca Meister5,6,
- Sybille Welker5,6,
- Sonal Asthana1,
- Pavle Boskovic7,
- Ka Hou Man7,
- Meike Schopp8,
- Paul Ginno8,
- Bernhard Radlwimmer7,
- Charles Erec Stebbins3,
- Thomas Miethke5,6,
- Fotini Nina Papavasiliou*,1 and
- Riccardo Pecori*,1
- 1Division of Immune Diversity, Department of Immunology and Cancer, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany
- 2Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany
- 3Division of Structural Biology of Infection and Immunity, Department of Immunology and Cancer, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany
- 4Institute of Clinical Chemistry, Medical Faculty of Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
- 5Institute of Medical Microbiology and Hygiene, Medical Faculty of Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
- 6Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty of Mannheim, University of Heidelberg, Ludolf-Krehl-Str. 13–17, 68167 Mannheim, Germany
- 7Division of Molecular Genetics, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany
- 8Division of Regulatory Genomics and Cancer Evolution, German Cancer Research Centre (DKFZ), Heidelberg, Germany
- ↵*These corresponding authors contributed equally. email: r.pecori{at}dkfz-heidelberg.de
Posted October 06, 2021.
ADESSO: a rapid, adaptable and sensitive Cas13-based COVID-19 diagnostic platform
